Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs United Airlines Holdings Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while United Airlines Holdings Inc trades at $107.46 (market cap $34.87B). The key difference: United Airlines Holdings Inc is far larger — about 5.8× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and United Airlines Holdings Inc for 46 Days on average.
| IOVA | UAL | |
|---|---|---|
Market Cap | $6.04B | $34.87B |
Volume | 14,805,993 | 6,329,678 |
Sector | Health | Industrials |
52-Week High | $14.82 | $136.11 |
52-Week Low | $1.81 | $85.21 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $5.97B | $51.90B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
United Airlines (UAL) trades at $107.46, down 2.46% with a bearish technical signal despite strong fundamentals. The stock shows attractive valuation metrics with P/E of 10.1 and P/S of 0.6, supported by consistent earnings beats and improving profitability. Recent news highlights aggressive customer acquisition strategies targeting Delta's premium travelers through status-match offers and Starlink-enabled WiFi advantages.
UAL presents a compelling value opportunity with analyst consensus price target of $158.10 (47% upside) and unanimous buy/hold ratings. However, near-term headwinds include rising fuel costs, labor expenses, and technical weakness. The company's strong cash flow generation and strategic positioning for premium customer capture support long-term growth prospects despite current market pessimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
